- Home
- AOMR vs CATX Comparison
AOMR vs CATX Comparison
Compare AOMR & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOMR
- CATX
- Stock Information
- Founded
- AOMR 2018
- CATX 1983
- Country
- AOMR United States
- CATX United States
- Employees
- AOMR N/A
- CATX N/A
- Industry
- AOMR Real Estate Investment Trusts
- CATX Medical/Dental Instruments
- Sector
- AOMR Real Estate
- CATX Health Care
- Exchange
- AOMR Nasdaq
- CATX Nasdaq
- Market Cap
- AOMR 224.3M
- CATX 239.0M
- IPO Year
- AOMR 2021
- CATX N/A
- Fundamental
- Price
- AOMR $9.30
- CATX $3.91
- Analyst Decision
- AOMR Strong Buy
- CATX Strong Buy
- Analyst Count
- AOMR 6
- CATX 10
- Target Price
- AOMR $11.25
- CATX $12.90
- AVG Volume (30 Days)
- AOMR 108.8K
- CATX 835.6K
- Earning Date
- AOMR 11-05-2025
- CATX 11-11-2025
- Dividend Yield
- AOMR 13.63%
- CATX N/A
- EPS Growth
- AOMR N/A
- CATX N/A
- EPS
- AOMR 1.56
- CATX N/A
- Revenue
- AOMR $57,661,000.00
- CATX $1,235,000.00
- Revenue This Year
- AOMR N/A
- CATX N/A
- Revenue Next Year
- AOMR $12.91
- CATX N/A
- P/E Ratio
- AOMR $6.01
- CATX N/A
- Revenue Growth
- AOMR N/A
- CATX N/A
- 52 Week Low
- AOMR $7.36
- CATX $1.60
- 52 Week High
- AOMR $10.88
- CATX $13.44
- Technical
- Relative Strength Index (RSI)
- AOMR 39.34
- CATX 62.78
- Support Level
- AOMR $9.30
- CATX $3.37
- Resistance Level
- AOMR $9.60
- CATX $3.78
- Average True Range (ATR)
- AOMR 0.14
- CATX 0.21
- MACD
- AOMR -0.02
- CATX 0.07
- Stochastic Oscillator
- AOMR 5.62
- CATX 90.32
About AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.